Remedium Lifecare Ltd.

As of June 30, 2025, Remedium Lifecare Ltd. trades at a trailing price-to-earnings ratio of 13.42.

As of June 30, 2025, Remedium Lifecare Ltd. trades at an EV/EBITDA multiple of 25.34 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.16 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 25.34 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Remedium Lifecare Ltd. trades at an EV/FCF ratio of 13.80, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of June 30, 2025, Remedium Lifecare Ltd. maintains a current ratio of 2.05, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 497.74, indicating elevated leverage, while an interest coverage ratio of 0.36 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2025. Return on capital employed (ROCE) is negative at -19.30, pointing to unprofitable operations over the period.

These figures cover the twelve months ended June 30, 2025. That works out to an effective tax rate of 34.33, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

Over the twelve months ended June 30, 2025, Remedium Lifecare Ltd. posted a gross margin of 2.50, reflecting its pricing power and cost economics. The operating margin of 0.62 and net profit margin of 1.17 provide insight into operational efficiency.

Remedium Lifecare Ltd.'s most recent stock split took place on July 5, 2024 with a 1:4 split ratio.

As of June 30, 2025, Remedium Lifecare Ltd. has an Altman Z-Score of 2.05, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.